Although the temporal relationship between low PAPP-A and free β-hCG levels and GDM is not fully understood, our findings suggest that the incorporation of early pregnancy maternal serum biomarkers into risk-prediction models could aid in the earlier identification of women at risk for GDM development. Here, PAPPA is linked to gestational diabetes.